We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
An image displaying a Newsletter on tablet, laptop & mobile

To continue reading this article, sign up for FREE to

Technology Networks logo


Membership is FREE and provides you with instant access to email newsletters, digital publications, our full content catalogue & more...

Expression Analysis Announces a GWAS Data Analysis and Resequencing Grant

Read time: Less than a minute

Part of the grant will include GWAS data analysis through a proprietary tool that simultaneously analyzes allelic and copy number variations, accomplishing in days what typically takes months.  The resequencing will be performed using Helicos True Single Molecule Sequencing (tSMS)™ technology.

The grant seeks projects that show promise of identifying genetic element(s) that are important to human health and disease.  There must be a strong case that the trait has a genetic basis and important health consequences. 

“With the recent advancements in detecting genetic variation and new next-generation sequencing technology, it is important to further research in efforts to identify additional genetic elements important to human health and disease,” stated Steve McPhail, CEO of Expression Analysis.  “The goal of this grant is to apply these technologies to assist researchers in identifying discreet genetic mechanisms of disease,” concluded McPhail.

Interested parties are encouraged to apply through the company’s web site: www.ExpressionAnalysis.com/Grant.  Applications are being accepted through December 15, 2008.